Kallikrein 11 Protein (KLK11) (His tag)
Kurzübersicht für Kallikrein 11 Protein (KLK11) (His tag) (ABIN7319354)
Target
Alle Kallikrein 11 (KLK11) Proteine anzeigenProtein-Typ
Spezies
Quelle
Reinheit
-
-
Aufreinigungstag / Konjugat
- Dieses Kallikrein 11 Protein ist gelabelt mit His tag.
-
Verwendungszweck
- Recombinant Human Kallikrein 11/KLK11 Protein (His Tag)
-
Sequenz
- Glu19-Asn250
-
Produktmerkmale
- Recombinant Human Kallikrein 11 is produced by our Mammalian expression system and the target gene encoding Glu19-Asn250 is expressed with a 6His tag at the C-terminus.
-
Endotoxin-Niveau
- < 1.0 EU per μg as determined by the LAL method.
-
-
Möchten Sie weitere Optionen für dieses Protein ?
!Entdecken Sie unsere vordefinierten maßgeschneiderten Proteine und Proteinservices!Ihr Projekt erfordert weitere Anpassungen? Kontaktieren Sie uns und entdecken Sie unsere maßgeschneiderten Proteinlösungen
-
-
-
Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
-
-
Format
- Frozen, Liquid
-
Buffer
- Supplied as a 0.2 μm filtered solution of 20 mM TrisHCl, 150 mM NaCl, 2 mM CaCl2, pH 8.0.
-
Lagerung
- -20 °C
-
Informationen zur Lagerung
- Store at < -20°C, stable for 6 months. Please minimize freeze-thaw cycles.
-
-
- Kallikrein 11 (KLK11)
-
Andere Bezeichnung
- Kallikrein 11/KLK11
-
Hintergrund
-
Background: Human Kallikrein 11 (KLK11) is a member of tissue kallikrein family which are extracellular serine proteases consisting of 15 members. Two isoforms of KLK11 are differentially expressed. Isoform 1 is predominantly expressed in brain and isoform 2 is preferentially expressed in prostate. Isoform 1 consists of a signal peptide,a short pro peptide and the mature chain.Isoform 2 contains an extra 32 amino acid N terminal to full-length isoform 1.KLK11 is a novel marker for ovarian and prostate cancer carcinomas. KLK11 can be activated by thermolysin and is active against a thioester substrate.
Synonym: Kallikrein-11, hK11, Hippostasin, Serine Protease 20, Trypsin-Like Protease, KLK11, PRSS20, TLSP
-
Molekulargewicht
- 26.3 kDa
-
NCBI Accession
- NP_006844
-
Pathways
- Komplementsystem
Target
-